Brii Bio Doses First Patient in Phase 2a/2b Clinical Trial of BRII-179 (VBI-2601) for the Functional Cure of Chronic Hepatitis B

Brii Bio Doses First Patient In Phase 2a/2b Clinical Trial Of Brii 179 (vbi 2601) For The Functional Cure Of Chronic Hepatitis B

Facebook Comments

Leave a Reply

CommentLuv badge